The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90
Open accessAbstract
Fungal pathogens exploit diverse mechanisms to survive exposure to antifungal drugs. This poses concern given the limited number of clinically useful antifungals and the growing population of immunocompromised individuals vulnerable to life-threatening fungal infection. To identify molecules that abrogate resistance to the most widely deployed class of antifungals, the azoles, we conducted a screen of 1,280 pharmacologically active compounds. Three out of seven hits that abolished azole resistance of a resistant mutant of the model yeast Saccharomyces cerevisiae and a clinical isolate of the leading human fungal pathogen Candida albicans were inhibitors of protein kinase C (PKC), which regulates cell wall integrity during growth, morphogenesis, and response to cell wall stress. Pharmacological or genetic impairment of Pkc1 conferred hypersensitivity to multiple drugs that target synthesis of the key cell membrane sterol ergosterol, including azoles, allylamines, and morpholines. Pkc1 enabled survival of cell membrane stress at least in part via the mitogen activated protein kinase (MAPK) cascade in both species, though through distinct downstream effectors. Strikingly, inhibition of Pkc1 phenocopied inhibition of the molecular chaperone Hsp90 or its client protein calcineurin. PKC signaling was required for calcineurin activation in response to drug exposure in S. cerevisiae. In contrast, Pkc1 and calcineurin independently regulate drug resistance via a common target in C. albicans. We identified an additional level of regulatory control in the C. albicans circuitry linking PKC signaling, Hsp90, and calcineurin as genetic reduction of Hsp90 led to depletion of the terminal MAPK, Mkc1. Deletion of C. albicans PKC1 rendered fungistatic ergosterol biosynthesis inhibitors fungicidal and attenuated virulence in a murine model of systemic candidiasis. This work establishes a new role for PKC signaling in drug resistance, novel circuitry through which Hsp90 regulates drug resistance, and that targeting stress response signaling provides a promising strategy for treating life-threatening fungal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“our analysis suggests all components of the Pkc1-MAPK pathway in C. albicans require Hsp90 for stability, including Pkc1, Bck1, Mkk2, and Mkc1”
From Functional Genomic Screening Reveals Core Modulators of Echinocandin Stress Responses in Candida albicans (2018) · cites this paper as LaFayette et al., 2010
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with the adjuvant drug responses, genes involved in several pathways, including calcineurin 53 and PKC signaling 44 , primarily affected FoG and not RAD (Fig. 4d, Supplementary Fig. 8, detailed information on genes tested in Supplementary Notes 2-4 and Supplementary Tables 2 and 3).”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [44]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In C. albicans, key client proteins of Hsp90 include the Ca2+-calmodulin-activated protein phosphatase calcineurin, and multiple members of the PKC-MAPK cell wall integrity cascade (Pkc1, Bck1, Mkk2 and Mkc1)75–78.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, Hsp90 inhibition blocks the activation of calcineurin-dependent stress responses and PKC signalling, abrogating tolerance and resistance to the azole and echinocandin drugs76,78.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“homozygous deletion of pathway components does not drastically alter Slt2/Mkc1 protein levels (LaFayette et al., 2010”
From Functional Genomic Screening Reveals Core Modulators of Echinocandin Stress Responses in Candida albicans (2018) · cites this paper as LaFayette et al., 2010
Experimental — accuracy not yet measured
19 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“The leading fungal pathogen of humans is Candida albicans, which ranks as the fourth most common cause of hospital acquired infectious disease and is associated with mortality rates approaching 50% [12,13,14].”
BackgroundFungal secondary metabolism — from biochemistry to genomics
Keller, N. P., Turner, G., & Bennett, J. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1286 · Cited by 1,731 · cited 1×
“Small molecules can have a dramatic effect on cellular signaling, mediate communication between microbes, or exert potentially lethal toxicity [3,4,5,6,7].”
BackgroundPratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483 · cited 1×
“Hsp90 is an essential molecular chaperone that regulates the stability and function of a diverse set of client proteins, many of which are regulators of cellular signaling [21,22,23].”
BackgroundClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 4×
“Alternatively, resistance can arise by mechanisms that minimize drug toxicity, such as loss of function of the ergosterol biosynthetic enzyme Erg3, which blocks the production of the toxic sterol that would otherwise accumulate when the azoles inhibit Erg11.”
BackgroundInfluentialBacteriocins: Evolution, Ecology, and Application
Riley, M. A., & Wertz, J. E. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161024 · Cited by 1,236 · cited 1×
“Small molecules can have a dramatic effect on cellular signaling, mediate communication between microbes, or exert potentially lethal toxicity [3,4,5,6,7].”
BackgroundChelerythrine is a potent and specific inhibitor of protein kinase C
Herbert, J. M., Augereau, J. M., Gleye, J., & Maffrand, J. P. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91544-3 · Cited by 1,195 · cited 1×
“Since the PKC inhibitors identified in our screen were characterized in mammalian cells [43,44], we next turned to other pharmacological inhibitors of PKC whose mode of action had been validated in fungi.”
BackgroundCell Wall Integrity Signaling in Saccharomyces cerevisiae
Levin, D. E. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.262-291.2005 · Cited by 1,136 · cited 8×
“SBF drives cell cyclespecific transcription and is also regulated by Slt2 in response to cell wall stress (reviewed in [30]).”
BackgroundInfluentialStructure and mechanism of the Hsp90 molecular chaperone machinery
Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103 · cited 1×
“Hsp90 is an essential molecular chaperone that regulates the stability and function of a diverse set of client proteins, many of which are regulators of cellular signaling [21,22,23].”
BackgroundBacterial Small-Molecule Signaling Pathways
Camilli, A., & Bassler, B. L. (2006) · Science · doi:10.1126/science.1121357 · Cited by 977 · cited 1×
“Small molecules can have a dramatic effect on cellular signaling, mediate communication between microbes, or exert potentially lethal toxicity [3,4,5,6,7].”
BackgroundZhao, R., Davey, M., Hsu, Y.-C., Kaplanek, P., Tong, A., Parsons, A. B., Krogan, N., Cagney, G., Mai, D., Greenblatt, J., et al. (2005) · Cell · doi:10.1016/j.cell.2004.12.024 · Cited by 819 · cited 1×
“cerevisiae [73,74], we identify Mkc1 as the second Hsp90 client protein in C.”
Background
Research works printed but not linked: 1
- G Paravicini, 1996, The C andida albicans PKC1 gene encodes a protein kinase C homolog necessary for cellular integrity but not dimorphism., Yeast, 12, 741, 10.1002/(SICI)1097-0061(19960630)12:8<741::AID-YEA967>3.0.CO;2-G · DOI
Cited by
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Self-citationMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“Hsp90 also stabilizes the terminal mitogen activated protein kinase (MAPK) of the cell wall integrity pathway, Mkc1, thereby modulating additional responses to azole-induced cell membrane stress (LaFayette et al. 2010).”
BackgroundInfluentialSelf-citationVerghese, J., Abrams, J., Wang, Y., & Morano, K. A. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05018-11 · Cited by 575
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
“albicans Hsp90 resulted in the destabilization of Mkc1, thereby blocking PKC signaling via the MAPK cascade (301).”
BackgroundInfluentialSelf-citationAntifungal drug resistance: evolution, mechanisms and impact
Revie, N. M., Iyer, K. R., Robbins, N., & Cowen, L. E. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.02.005 · Cited by 516
Self-citationMolecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441
Self-citationAmphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
Carolus, H., Pierson, S., Lagrou, K., & Van Dijck, P. (2020) · Journal of Fungi · doi:10.3390/jof6040321 · Cited by 349
“The connection between Hsp90 and antifungal resistance can be investigated through the use of Hsp90 inhibitors such as geldanamycin and radicicol [73,74].”
BackgroundFitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., & Lindquist, S. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001692 · Cited by 322
“The erg3 erg11 strains were slightly less sensitive to calcineurin inhibitors, but showed a dramatically increased sensitivity to PKC inhibition.”
BackgroundMethodInfluentialMechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313
Molecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304
“In S. cerevisiae , Rlm1 is the major regulator of cell wall integrity and its transcriptional output includes genes involved in cell wall biogenesis, while SBF is a cell cycle transcription factor that regulates the transcription of cell wall-related genes including FKS2 under conditions of cell wall stress 84 .”
InfluentialSelf-citationHsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291
“In stark contrast, Cna1 and Mkc1 remain stable in biofilms, despite reduction of Hsp90 levels (Figure 6).”
BackgroundMethodSelf-citationRosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Virulence Factors in Candida species
Staniszewska, M. (2020) · Current Protein & Peptide Science · doi:10.2174/1389203720666190722152415 · Cited by 279
Antifungal Drugs: The Current Armamentarium and Development of New Agents
Robbins, N., Wright, G. D., & Cowen, L. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0002-2016 · Cited by 271
“In a series of clinical isolates recovered over time from an HIV-infected patient treated with fl uconazole, the basal fl uconazole resistance phenotypes of isolates recovered early during treatment were dependent on Hsp90, calcineurin, and Pkc1 function (82, 105).”
BackgroundInfluentialSelf-citationImmune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 264
Antifungal drug-resistance mechanisms in Candida biofilms
Kaur, J., & Nobile, C. J. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102237 · Cited by 261
“Indeed, pharmacological inhibition of calcineurin or Hsp90 is synergistic with fluconazole against C. albicans biofilms [21,47].”
Role of Heat-Shock Proteins in Cellular Function and in the Biology of Fungi
Tiwari, S., Thakur, R., & Shankar, J. (2015) · Biotechnology Research International · doi:10.1155/2015/132635 · Cited by 255
“Thus, current review focuses on role of Hsps in fungi during morphogenesis and various stress conditions (temperature, pH, and osmotic pressure) and in antifungal drug tolerance.”
BackgroundCombinatorial strategies for combating invasive fungal infections
Spitzer, M., Robbins, N., & Wright, G. D. (2017) · Virulence · doi:10.1080/21505594.2016.1196300 · Cited by 218
Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Lee, K. K., MacCallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. R., & Munro, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00683-11 · Cited by 209
“The cell wall signaling network, including the PKC, HOG, and Ca2 /calcineurin pathways, activates CHS expression in response to echinocandins, cations, or CFW (11, 22, 33, 35, 47, 70).”
BackgroundGlobal Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 205
Self-citationInhibition of gold nanoparticles (AuNPs) on pathogenic biofilm formation and invasion to host cells
Yu, Q., Li, J., Zhang, Y., Wang, Y., Liu, L., & Li, M. (2016) · Scientific Reports · doi:10.1038/srep26667 · Cited by 201
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species
Czajka, K. M., Venkataraman, K., Brabant-Kirwan, D., Santi, S. A., Verschoor, C., Appanna, V. D., Singh, R., Saunders, D. P., & Tharmalingam, S. (2023) · Cells · doi:10.3390/cells12222655 · Cited by 180
“Finally, the Hsp90 molecule may have a regulatory role with key resistance regulators like Mkc1 from the Pkc1 signaling pathway [184,185].”
BackgroundJuvvadi, P. R., Lee, S. C., Heitman, J., & Steinbach, W. J. (2017) · Virulence · doi:10.1080/21505594.2016.1201250 · Cited by 172
“albicans.(111) Hsp90 stabilizes calcineurin by direct interactions so the inhibition of Hsp90 is expected to result in depletion or inactivity of the client protein calcineurin.”
BackgroundSynergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans
Cui, J., Ren, B., Tong, Y., Dai, H., & Zhang, L. (2015) · Virulence · doi:10.1080/21505594.2015.1039885 · Cited by 171
“PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90.”
BackgroundInfluentialNovel Agents and Drug Targets to Meet the Challenges of Resistant Fungi
McCarthy, M. W., Kontoyiannis, D. P., Cornely, O. A., Perfect, J. R., & Walsh, T. J. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix130 · Cited by 169
“may find clinical utility in combination therapy [78].”
BackgroundSelf-citationLiu, S., Hou, Y., Chen, X., Gao, Y., Li, H., & Sun, S. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.12.009 · Cited by 154
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145
“the activation of efflux pumps (Figure 1) [29,31].”
BackgroundCell wall integrity signalling in human pathogenic fungi: CWI signalling in pathogenic fungi
Dichtl, K., Samantaray, S., & Wagener, J. (2016) · Cellular Microbiology · doi:10.1111/cmi.12612 · Cited by 144
Heat Shock Protein 90 Is Required for Conidiation and Cell Wall Integrity in Aspergillus fumigatus
Lamoth, F., Juvvadi, P. R., Fortwendel, J. R., & Steinbach, W. J. (2012) · Eukaryotic Cell · doi:10.1128/ec.00032-12 · Cited by 136
Kim, S. H., Iyer, K. R., Pardeshi, L., Muñoz, J. F., Robbins, N., Cuomo, C. A., Wong, K. H., & Cowen, L. E. (2019) · mBio · doi:10.1128/mbio.02529-18 · Cited by 136
Self-citationResistance of Candida spp. to antifungal drugs in the ICU: where are we now?
Maubon, D., Garnaud, C., Calandra, T., Sanglard, D., & Cornet, M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3404-7 · Cited by 162
Leach, M. D., Budge, S., Walker, L. A., Munro, C. A., Cowen, L. E., & Brown, A. J. P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003069 · Cited by 146
“To test this we determined the impact of Hsp90 depletion on Cek1 stability as Hsp90 client proteins are generally destabilised in the absence of Hsp90 [62,86,89].”
BackgroundInfluentialSelf-citationFan, F., Liu, Y., Liu, Y., Lv, R., Sun, W., Ding, W., Cai, Y., Li, W., Liu, X., & Qu, W. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106673 · Cited by 159
Lysine Deacetylases Hda1 and Rpd3 Regulate Hsp90 Function thereby Governing Fungal Drug Resistance
Robbins, N., Leach, M. D., & Cowen, L. E. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.035 · Cited by 126
“Immunoblot Analysis and Immunoprecipitation Total protein extracts were prepared as described previously (LaFayette et al., 2010; Robbins et al., 2011).”
BackgroundMethodSelf-citationStructural basis for species-selective targeting of Hsp90 in a pathogenic fungus
Whitesell, L., Robbins, N., Huang, D. S., McLellan, C. A., Shekhar-Guturja, T., LeBlanc, E. V., Nation, C. S., Hui, R., Hutchinson, A., Collins, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08248-w · Cited by 124
Self-citationHeilmann, C. J., Sorgo, A. G., Mohammadi, S., Sosinska, G. J., de Koster, C. G., Brul, S., de Koning, L. J., & Klis, F. M. (2013) · Eukaryotic Cell · doi:10.1128/ec.00278-12 · Cited by 122
“A variety of pathways are involved in cell wall maintenance including the Mkc1, Hog1, Msb2-Cek1, and calcineurin pathways as well as the chaperone Hsp90, which all have been shown to be involved in the regulation of chitin synthase expression (11, 25, 62).”
BackgroundAntifungals and Drug Resistance
Hossain, C. M., Ryan, L. K., Gera, M., Choudhuri, S., Lyle, N., Ali, K. A., & Diamond, G. (2022) · Encyclopedia · doi:10.3390/encyclopedia2040118 · Cited by 162
“Echinocandin drug tolerance and protective mechanisms like upregulating chitin production are made possible by cell wall integrity signaling, which is regulated by the protein phosphatase calcineurin, the protein kinase C (PKC), and the molecular chaperone Hsp90 [99].”
BackgroundSorgo, A. G., Heilmann, C. J., Dekker, H. L., Bekker, M., Brul, S., de Koster, C. G., de Koning, L. J., & Klis, F. M. (2011) · Eukaryotic Cell · doi:10.1128/ec.05011-11 · Cited by 120
“albicans (32), and phosphorylation of the MAP kinase Mkc1 increases upon exposure to the membrane-perturbing agent chlorpromazine (31).”
BackgroundDefining the frontiers between antifungal resistance, tolerance and the concept of persistence
Delarze, E., & Sanglard, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.001 · Cited by 118
Diezmann, S., Michaut, M., Shapiro, R. S., Bader, G. D., & Cowen, L. E. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002562 · Cited by 112
“Both established C. albicans client proteins that require Hsp90 for stability, Cna1 [19] and Mkc1 [18], were also low-connectivity interactors.”
BackgroundInfluentialSelf-citationCurcumin Targets Cell Wall Integrity via Calcineurin-Mediated Signaling in Candida albicans
Kumar, A., Dhamgaye, S., Maurya, I. K., Singh, A., Sharma, M., & Prasad, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01385-13 · Cited by 117
MacAlpine, J., Daniel-Ivad, M., Liu, Z., Yano, J., Revie, N. M., Todd, R. T., Stogios, P. J., Sánchez, H., O’Meara, T. R., Tompkins, T. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26390-w · Cited by 126
Self-citationAdvancements and challenges in antifungal therapeutic development
Puumala, E., Fallah, S., Robbins, N., & Cowen, L. E. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00142-23 · Cited by 138
Self-citationCalcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis
Chen, Y.-L., Brand, A., Morrison, E. L., Silao, F. G. S., Bigol, U. G., Malbas, F. F., Nett, J. E., Andes, D. R., Solis, N. V., Filler, S. G., et al. (2011) · Eukaryotic Cell · doi:10.1128/ec.00310-10 · Cited by 107
“albicans often result in attenuated virulence in murine systemic infection models (19, 46, 51).”
BackgroundFungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs
Leach, M. D., Klipp, E., Cowen, L. E., & Brown, A. J. P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2875 · Cited by 107
Self-citationBrown, A. J. P., Cowen, L. E., Pietro, A. D., & Quinn, J. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0048-2016 · Cited by 125
“Hsp90 stabilizes the terminal MAPK in the cell wall integrity pathway, Slt2 in S. cerevisiae , and Mkc1 in C. albicans (139 – 141).”
BackgroundSelf-citationNishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Gong, Y., Li, T., Yu, C., & Sun, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00520 · Cited by 114
“…in Cellular and Infection Microbiology | www.frontiersin.org 7 December 2017 | Volume 7 | Article 520 is responsible for maintaining the integrity of the cell wall during growth, morphogenesis, and cell wall stress in C. albicans (Navarro-García et al., 1995; Lafayette et al., 2010).”
BackgroundInfluentialElucidating Drug Resistance in Human Fungal Pathogens
Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 127
Self-citationpH Signaling in Human Fungal Pathogens: a New Target for Antifungal Strategies
Cornet, M., & Gaillardin, C. M. (2014) · Eukaryotic Cell · doi:10.1128/ec.00313-13 · Cited by 110
Protein kinase C in fungi—more than just cell wall integrity
Heinisch, J. J., & Rodicio, R. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux051 · Cited by 100
“…by guest on 16 M arch 2020 impairment of the wall usually leads to cell lysis, PKC itself and other components of the signaling cascade are promising targets for the development of antifungal drugs (Heinisch 2005; LaFayette et al. 2010).”
BackgroundThe fungal Achilles’ heel: targeting Hsp90 to cripple fungal pathogens
Cowen, L. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.005 · Cited by 104
Self-citationHayes, B. M. E., Anderson, M. A., Traven, A., van der Weerden, N. L., & Bleackley, M. R. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1573-8 · Cited by 93
Mechanisms of Candida albicans Trafficking to the Brain
Liu, Y., Mittal, R., Solis, N. V., Prasadarao, N. V., & Filler, S. G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002305 · Cited by 93
“in mice or the susceptibility of mutant strains of mice to disseminated candidiasis”
BackgroundGenetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93
“The azole resistance phenotype was independent of calcineurin but dependent on Hsp90 (Figure 6), suggesting a resistance mechanism that is contingent upon distinct Hsp90 downstream effectors, such as Mkc1 [74].”
BackgroundSelf-citationThe Hsp90 chaperone network modulates Candida virulence traits
O’Meara, T. R., Robbins, N., & Cowen, L. E. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.05.003 · Cited by 92
“The PKC mitogen-activated protein kinase (MAPK) cascade is required for tolerance to both the echinocandins [69] and azoles [70], which are the most widely deployed classes of antifungal drugs.”
InfluentialSelf-citationChemosensitization as a Means to Augment Commercial Antifungal Agents
Campbell, B. C., Chan, K. L., & Jong Heon, K. I. M. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00079 · Cited by 91
Lu, H., Hong, T., Jiang, Y., Whiteway, M. S., & Zhang, S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114960 · Cited by 119
The role of Candida albicans stress response pathways in antifungal tolerance and resistance
Iyer, K. R., Robbins, N., & Cowen, L. E. (2022) · iScience · doi:10.1016/j.isci.2022.103953 · Cited by 88
Self-citationDrug resistance mechanisms and their regulation in non- albicans Candida species
Kołaczkowska, A., & Kołaczkowski, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv445 · Cited by 113
Xu, T., Cao, L., Zeng, J., Franco, C. M. M., Yang, Y., Hu, X., Liu, Y., Wang, X., Gao, Y., Bu, Z., et al. (2019) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2019.06.015 · Cited by 90
The Hsp90 Co-Chaperone Sgt1 Governs Candida albicans Morphogenesis and Drug Resistance
Shapiro, R. S., Zaas, A. K., Betancourt-Quiroz, M., Perfect, J. R., & Cowen, L. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044734 · Cited by 86
“Cidality Assays Cidality was established essentially as previously described [38].”
BackgroundMethodSelf-citationThe effect of biomaterials and antifungals on biofilm formation by Candida species: a review
Cuéllar‐Cruz, M., Vega‐González, A., Mendoza‐Novelo, B., López-Romero, E., Ruiz‐Baca, E., Escorza, M. A. Q., & Villagómez-Castro, J. C. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1634-6 · Cited by 102
“They are commonly treated with azole-based antifungal medication, which inhibit the ergosterol biosynthetic pathway, a specific sterol of Candida plasma membrane [10–14], generating an accumulation of a toxic sterol intermediate that disrupts the cell membrane [15–17].”
BackgroundShapiro, R. S., Sellam, A., Tebbji, F., Whiteway, M., Nantel, A., & Cowen, L. E. (2012) · Current Biology · doi:10.1016/j.cub.2012.01.062 · Cited by 81
Self-citationCandida albicans targets that potentially synergize with fluconazole
Lu, H., Shrivastava, M., Whiteway, M., & Jiang, Y. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1884641 · Cited by 81
“Deletion strains for the PKC1 gene, the BCK1 gene, and the MKC1 gene all exhibited increased fluconazole sensitivity (Epp, Vanier, et al. 2010; LaFayette et al. 2010).”
BackgroundInfluentialSun, H., Liu, J., Zheng, Y., Pan, Y., Zhang, K., & Chen, J. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.05.002 · Cited by 83
“In addition, PKC also contributes to the activation of Ser/Thr phosphatase PP2B (LaFayette et al., 2010).”
BackgroundInfluentialRobbins, N., Spitzer, M., Yu, T., Cerone, R. P., Averette, A. K., Bahn, Y.-S., Heitman, J., Sheppard, D. C., Tyers, M., & Wright, G. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.018 · Cited by 78
“Immunoblotting was conducted as described previously (LaFayette et al., 2010).”
BackgroundMethodInfluentialResistance mechanism and proteins in Aspergillus species against antifungal agents
Shishodia, S. K., Tiwari, S., & Shankar, J. (2019) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2019.1574927 · Cited by 96
“In case of CAS drug treatment which involves drug resistance through calcineurin function, the activation of downstream MAPK pathway was also noted (LaFayette et al. 2010).”
BackgroundŌmura, S., Asami, Y., & Crump, A. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0029-z · Cited by 83
“It potentiates the efficacy of azoles and echinocandins via inhibition of Pkc1 [73] and induces fungal morphogenesis via a mechanism that is independent of Pkc1 but which involves adenyl cyclase Cyr1 and the cyclic AMP-dependent protein kinase A (cAMP-PKA).”
BackgroundDouglas, L. M., Wang, H. X., Keppler‐Ross, S., Dean, N., & Konopka, J. B. (2011) · mBio · doi:10.1128/mbio.00254-11 · Cited by 85
“Interestingly, pkc1 mutants are more sensitive than the wild type to fluconazole (54), an inhibitor of ergosterol synthesis, suggesting that an impaired Pkc1 pathway in sur7 cells may contribute to the observed 5-foldincreased sensitivity of these cells to fluconazole (27).”
BackgroundHameed, S., Dhamgaye, S., Singh, A., Goswami, S. K., & Prasad, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018684 · Cited by 69
“albicans [28].”
Combination Therapy to Treat Fungal Biofilm-Based Infections
Tits, J., Cammue, B. P. A., & Thevissen, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228873 · Cited by 82
Senn, H., Shapiro, R. S., & Cowen, L. E. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-08-0729 · Cited by 67
“The only other two Hsp90 client proteins identified to date include the protein phosphatase calcineurin and the MAP kinase Mkc1, which are key regulators of the evolution and maintenance of antifungal drug resistance (Singh et al., 2009; LaFayette et al., 2010).”
BackgroundSelf-citationSesamol: A Natural Phenolic Compound with Promising Anticandidal Potential
Ansari, M. A., Fatima, Z., & Hameed, S. (2014) · Journal of Pathogens · doi:10.1155/2014/895193 · Cited by 69
“Cell wall integrity pathway (CWI) has been linked to calcineurin signaling pathway for having implications in governing responses toward survival of exposure to antifungal drugs [18].”
BackgroundRisks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease
Zimmerman, O., Rösler, B., Zerbe, C. S., Rosen, L. B., Hsu, A. P., Uzel, G., Freeman, A. F., Sampaio, E. P., Rosenzweig, S. D., Kuehn, H. S., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx202 · Cited by 67
“Staurosporine also reduced azole resistance in clinical isolates [16].”
Yu, Q., Wang, F., Zhao, Q., Chen, J., Zhang, B., Ding, X., Wang, H., Yang, B., Lu, G., Zhang, B., et al. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.11.022 · Cited by 69
Anticandidal Effect and Mechanisms of Monoterpenoid, Perillyl Alcohol against Candida albicans
Ansari, M. A., Fatima, Z., & Hameed, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162465 · Cited by 67
“wall and also linked with calcineurin signaling suggesting crosstalk [39, 42, 43].”
BackgroundUnderstanding the mechanisms of resistance to azole antifungals in Candida species
Li, Y., Hind, C. K., Furner-Pardoe, J., Sutton, J. M., & Rahman, K. M. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf106 · Cited by 77
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 77
“albicans is an important regulator of antifungal drug resistance [172].”
BackgroundVincent, B. M., Langlois, J.-B., Srinivas, R., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., Tidor, B., Buchwald, S. L., & Lindquist, S. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.06.016 · Cited by 58
“…by 10μM Inz-1 to that of other small molecules that sensitize C. albicans to azoles, including inhibitors of Hsp90, Calcineurin, PKC, histone deacetylases, PKA, and ARF cycling (Cowen and Lindquist, 2005; Epp et al., 2010; LaFayette et al., 2010; Marchetti et al., 2000; Smith and Edlind, 2002).”
InfluentialNew antifungal strategies: Drug combination and co-delivery
Zhu, P., Li, Y., Guo, T., Liu, S., Tancer, R. J., Hu, C., Zhao, C., Xue, C., & Liao, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114874 · Cited by 63
Lewis, R. E., Ben‐Ami, R., Best, L., Albert, N. D., Walsh, T. J., & Kontoyiannis, D. P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis767 · Cited by 62
“target the cell membrane or cell wall [34, 36].”
BackgroundDesign and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors
Huang, D. S., LeBlanc, E. V., Shekhar‐Guturja, T., Robbins, N., Krysan, D. J., Pizarro, J. C., Whitesell, L. J., Cowen, L. E., & Brown, L. E. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00826 · Cited by 70
Self-citationNovel Strategies to Combat the Emerging Drug Resistance in Human Pathogenic Microbes
Qadri, H., Shah, A. H., & Mir, M. A. (2020) · Current Drug Targets · doi:10.2174/1389450121666201228123212 · Cited by 76
Xie, J. L., Qin, L., Miao, Z., Grys, B. T., Diaz, J. D. L. C., Ting, K., Krieger, J. R., Tong, J., Tan, K., Leach, M. D., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00547-y · Cited by 60
Self-citationYu, Q., Ding, X., Xu, N., Cheng, X., Qian, K., Zhang, B., Xing, L., & Li, M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.009 · Cited by 60
“[5] LaFayette SL, Collins C, Zaas AK, Schell WA, Betancourt-Quiroz M, Gunatilaka AA, et al.”
BackgroundSingh, S., Fatima, Z., & Hameed, S. (2016) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0190-2016 · Cited by 63
“The CWI regulates key cellular responses that are important for survival after the exposure of cells to antifungal drugs that target the cell wall and phenocopies compromised calcineurin signaling(21).”
BackgroundBaxter, B. K., DiDone, L., Ogu, D., Schor, S., & Krysan, D. J. (2011) · ACS Chemical Biology · doi:10.1021/cb100399x · Cited by 61
“Staurosporine has been shown to be synergistic with fluconazole (31) and we suspect that the synergy displayed by UCN-01 may be due to its structural similarity to staurosporine.”
BackgroundEl‐Sayed, A. S. A., Ali, D. M. I., Yassin, M. A., Zayed, R., & Ali, G. S. (2018) · Process Biochemistry · doi:10.1016/j.procbio.2018.10.008 · Cited by 59
Rocha, M. C., de Godoy, K. F., de Castro, P. A., Hori, J. I., Bom, V. L. P., Brown, N. A., da Cunha, A. F., Goldman, G. H., & Malavazi, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135195 · Cited by 63
Overcoming Fungal Echinocandin Resistance through Inhibition of the Non-essential Stress Kinase Yck2
Caplan, T., Lorente-Macías, Á., Stogios, P. J., Evdokimova, E., Hyde, S., Wellington, M. A., Liston, S., Iyer, K. R., Puumala, E., Shekhar-Guturja, T., et al. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.12.008 · Cited by 57
“, 2016), a key virulence trait and attenuates virulence in a mouse model of disseminated candidiasis (LaFayette et al., 2010).”
BackgroundSelf-citationHeat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus
Lamoth, F., Juvvadi, P. R., & Steinbach, W. J. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.947239 · Cited by 80
“Similar finding was observed for the MAPK Mkc1, another known downstream effector of Hsp90 in antifungal resistance pathways in yeasts (Diezmann et al., 2012; LaFayette et al., 2010).”
ResultYu, Q., Wang, H., Xu, N., Cheng, X., Wang, Y., Zhang, B., Xing, L., & Li, M. (2012) · Microbiology · doi:10.1099/mic.0.057232-0 · Cited by 60
Singh, S., Fatima, Z., & Hameed, S. (2016) · Archives of Microbiology · doi:10.1007/s00203-016-1205-9 · Cited by 63
“Cell wall integrity pathway (CWI) is another signaling cascade known to regulate key cellular responses crucial for survival of exposure to antifungal drugs targeting the cell wall and known to be linked with calcineurin signaling (LaFayette et al. 2010).”
BackgroundVirulence and Biofilms As Promising Targets in Developing Antipathogenic Drugs Against Candidiasis
Khan, M. S., Alshehrei, F. M., Alghamdi, S., Bamaga, M. A., Althubiani, A. S., & Alam, M. Z. (2020) · Future Science OA · doi:10.2144/fsoa-2019-0027 · Cited by 69
Caplan, T., Polvi, E. J., Xie, J. L., Buckhalter, S., Leach, M. D., Robbins, N., & Cowen, L. E. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.084 · Cited by 56
Self-citationThe effect of antifungal resistance development on the virulence of Candida species
Bohner, F., Papp, C., & Gácser, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac019 · Cited by 77
“Such regulators include the protein phosphatase calcineurin, as well as the terminal mitogen-activated protein kinase (Mkc1) of the Pkc1 signaling cascade (Cowen and Steinbach 2008, Lafayette et al. 2010).”
Delavy, M., Cerutti, L., Croxatto, A., Prod’hom, G., Sanglard, D., Greub, G., & Coste, A. T. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03000 · Cited by 62
“Previous studies effectively shown that calcineurin is involved in tolerance but also resistance through the Pkc1 and TOR pathways (Cowen et al., 2006; LaFayette et al., 2010; Robbins et al., 2010).”
BackgroundAntifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 65
“Inhibition of HSP90 , a chaperone protein, prevents the activation of PKC signaling and calcineurin-dependent stress responses, eliminating resistance to azole and echinocandin drugs [114,115].”
Background
Metadata
- Authors
- LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Duke Medical Center (US)
- University of Arizona (US)
- Corresponding author
- Cowen, Leah E.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-08-26
- Volume
- 6
- Issue
- 8
- Pages
- e1001069
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2928802
- OpenAlex
- W2045507047
- Cited by
- 329
- References
- 84
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 19 · 2023: 21 · 2022: 25 · 2021: 25 · 2020: 19 · 2019: 16 · 2018: 22 · 2017: 19 · 2016: 24 · 2015: 15 · 2014: 21 · 2013: 19 · 2012: 27
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Figshare (submittedVersion, cc-by)
- Funders
- Burroughs Wellcome Fund
- National Institutes of Health
- U.S. Public Health Service (MOP-86452)
- Canadian Institutes of Health Research (MOP-86452)
- Natural Sciences and Engineering Research Council of Canada (355965-2009)
- National Institute of Allergy and Infectious Diseases (AI 73896, R56AI028388, AI28388, R01AI073896, R01AI028388, K08AI065837)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida albicans, azole resistance, antifungal resistance, protein kinase C, PKC1, calcineurin, HSP90, MAPK signaling, cell wall integrity, ergosterol biosynthesis, systemic candidiasis, fungal virulence, stress signaling
- MeSH terms
- Animals, Antifungal Agents, Candida albicans, Fungal Proteins, Microbial Sensitivity Tests, Protein Kinase C, Saccharomyces cerevisiae, Immunoblotting, Signal Transduction, HSP90 Heat-Shock Proteins, Calcineurin, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, Drug Resistance, Fungal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.